Threda
NDC 53145-057
Product Information
Threda is a OTC MONOGRAPH FINAL-approved product labeled by Menper Distributors, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 53145-057 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 53145-057?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZOIC ACID (UNII: 8SKN0B0MIM)
- MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
- METHYLCELLULOSE (100 CPS) (UNII: 4GFU244C4J)
- D&C RED NO. 22 (UNII: 1678RKX8RT)
- D&C RED NO. 28 (UNII: 767IP0Y5NH)
- SODIUM SALICYLATE (UNII: WIQ1H85SYP)
- SORBIC ACID (UNII: X045WJ989B)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- SALICYLIC ACID (UNII: O414PZ4LPZ)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1437923 - THREDA 262 MG in 15 mL Oral Suspension
- RxCUI: 1437923 - bismuth subsalicylate 17.5 MG/ML Oral Suspension [Threda]
- RxCUI: 1437923 - Threda 17.5 MG/ML Oral Suspension
- RxCUI: 1437923 - Threda 262 MG per 15 ML Oral Suspension
- RxCUI: 308762 - bismuth subsalicylate 525 MG in 30 mL Oral Suspension
* Please review the full disclaimer at the bottom of this page.